Aldeyra Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Aldeyra Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q3 2024.
  • Aldeyra Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$15.1M, a 84.6% decline year-over-year.
  • Aldeyra Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$44.8M, a 1.96% increase year-over-year.
  • Aldeyra Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$37.5M, a 39.5% increase from 2022.
  • Aldeyra Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$62M, a 7.35% decline from 2021.
  • Aldeyra Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$57.8M, a 53.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$44.8M -$15.1M -$6.93M -84.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$37.9M -$16.8M -$7.86M -87.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$30M -$8.08M +$7.53M +48.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$37.5M -$4.75M +$8.15M +63.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$45.7M -$8.19M +$6.37M +43.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$52.1M -$8.99M +$8.79M +49.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$60.9M -$15.6M +$1.17M +6.99% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$62M -$12.9M +$2.85M +18.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$64.9M -$14.6M +$1.24M +7.86% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$66.1M -$17.8M -$2.84M -19% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$63.3M -$16.8M -$5.5M -48.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$57.8M -$15.8M -$4.46M -39.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$53.3M -$15.8M -$6.92M -78% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$46.4M -$14.9M -$7.42M -98.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$39M -$11.3M -$1.42M -14.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$37.6M -$11.3M +$1.87M +14.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$39.4M -$8.87M +$9.84M +52.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 -$49.3M -$7.52M +$5.81M +43.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$55.1M -$9.87M +$5.76M +36.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$60.8M -$13.2M -$2.53M -23.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$58.3M -$18.7M -$7.9M -73.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$50.4M -$13.3M -$4.28M -47.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$46.1M -$15.6M -$7.23M -86.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$38.9M -$10.6M -$3.68M -52.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$35.2M -$10.8M -$5.83M -117% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$29.4M -$9.05M -$3.74M -70.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$25.6M -$8.4M -$3.31M -64.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$22.3M -$6.95M -$2.3M -49.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 -$20M -$4.99M -$211K -4.42% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$19.8M -$5.31M -$1.01M -23.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$18.8M -$5.09M -$124K -2.49% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
Q4 2016 -$18.7M -$4.65M -$298K -6.85% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-30
Q3 2016 -$18.4M -$4.78M -$1.41M -41.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$17M -$4.3M -$2.07M -92.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$14.9M -$4.97M -$2.83M -132% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$12.1M -$4.36M -$1.91M -78.2% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$10.2M -$3.37M -$1.36M -67.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$8.82M -$2.23M -$1.1M -96.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 -$7.73M -$2.14M -$2.54M -632% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$5.19M -$2.44M -$11.7M -126% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $6.55M -$2.01M -$11.3M -122% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $17.9M -$1.14M +$434K +27.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $17.4M $402K +$4.38M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $13.1M $9.3M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-23
Q3 2013 $9.31M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$1.57M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$3.97M Jan 1, 2013 Mar 31, 2013 10-Q 2014-06-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.